Breathe Well Live Well
Conditions: Asthma; Rhinovirus; Picornaviridae Infections; Common Cold
Interventions: Drug: OC459; Drug: Placebo; Other: Rhinovirus
Sponsors: Imperial College London; Medical Research Council; Atopix Therapeutics, Ltd.
Recruiting – verified January 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
News-Medical.net |
Atopix raises additional development capital to investigate OC459 for …
News-Medical.net Atopix Therapeutics Limited ("Atopix"), a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product … |
View full post on asthma – Google News
|
Atopix reports positive results from Phase IIb asthma study with OC459 compound
News-Medical.net Atopix Therapeutics Ltd ("Atopix"), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the results of a Phase IIb asthma study with their lead compound OC459 at the American Academy of Allergy, Asthma … |
View full post on asthma – Google News